Peptide entry

Thymosin Alpha-1

Research peptidePeptide

Quick facts

Category
Immune
Primary goal
Immune Support
Dose pattern
Weekly
Treatment style
Fixed-dose or range
Status
Research peptide
Vial formats
10 mg

Evidence / context

Evidence: Limited. Immune-modulation support context varies by protocol.

Available vial formats

Thymosin Alpha-1

10 mg
Mix 3.0 mLConcentration 3.33 mg/mL

Dosing

  • Conservative 1.5 mg per injection, 2 times weekly (45 units per injection)
  • Standard 1.5 mg per injection, 3 times weekly (45 units per injection)
  • Aggressive 1.5 mg per injection, 4 times weekly (45 units per injection) short block
Cycle length6-10 weeks
TimingMorning on consistent days.

Reconstitution

  1. Swab vial tops with alcohol
  2. Draw 3.0 mL bacteriostatic water
  3. Inject slowly down vial wall (don't blast powder)
  4. Gently swirl - do not shake
  5. Rest 5-10 min to dissolve
  6. Refrigerate 2-8 C

Support / expected effects

Side effects / tolerability

Practical tips

Storage

Refrigerated: ~45-60 days.

Notes / compatibility

Compatibility

Rule: only mix water-based peptides sharing the same diluent and timing intent. If unsure, keep separate.

FAQ

What is Thymosin Alpha-1 explored for?

Immune modulation/resilience support. May reduce flare frequency in some protocols. Useful during stressful periods with good sleep.

How is Thymosin Alpha-1 reconstituted?

1) Swab vial tops with alcohol 2) Draw 3.0 mL bacteriostatic water 3) Inject slowly down vial wall (don't blast powder) 4) Gently swirl - do not shake 5) Rest 5-10 min to dissolve 6) Refrigerate 2-8 C

What is a typical cycle length for Thymosin Alpha-1?

6-10 weeks

How are doses measured in syringe units here?

Units mean U-100 insulin-syringe gradations (1 mL = 100 units), not International Units. Use the calculator only when the vial concentration and injection volume are known.

Calculate the exact draw for Thymosin Alpha-1Preloads the relevant vial format or fixed-ratio blend cycle.
Open calculator